Channel 2 Mon, 01.03.2021 14:30 - 15:45
Date
Mon, 01.03.2021
Room
Channel 2
Chairs
  • Giuseppe Curigliano (Milan, Italy)
  • Noboru Yamamoto (Chuo-ku, Japan)
Antibody-drug conjugate (ADC) technology Educational session

Clinical development of next generation ADCs (ID 35)

Lecture Time
14:30 - 14:45
Speakers
  • Anthony W. Tolcher (San Antonio, TX, United States of America)
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Anthony W. Tolcher (San Antonio, TX, United States of America)
Antibody-drug conjugate (ADC) technology Educational session

Re-positioning the payload (ID 36)

Lecture Time
14:45 - 15:00
Speakers
  • Noboru Yamamoto (Chuo-ku, Japan)
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Noboru Yamamoto (Chuo-ku, Japan)
Antibody-drug conjugate (ADC) technology Educational session

ADCs and new targets in solid tumours (ID 37)

Lecture Time
15:00 - 15:15
Speakers
  • Giuseppe Curigliano (Milan, Italy)
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Giuseppe Curigliano (Milan, Italy)
Antibody-drug conjugate (ADC) technology Educational session

Tumour-targeted immune-stimulating antibody conjugates (ISACs): A new class of immuno-oncology therapeutics (ID 38)

Lecture Time
15:15 - 15:30
Speakers
  • Shelley Ackerman (Redwood City, CA, United States of America)
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Shelley Ackerman (Redwood City, CA, United States of America)
Antibody-drug conjugate (ADC) technology Educational session

Live Q&A and discussion (ID 39)

Lecture Time
15:30 - 15:45
Speakers
  • Giuseppe Curigliano (Milan, Italy)
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Giuseppe Curigliano (Milan, Italy)
  • Noboru Yamamoto (Chuo-ku, Japan)
  • Anthony W. Tolcher (San Antonio, TX, United States of America)
  • Shelley Ackerman (Redwood City, CA, United States of America)